Amount Raised
$200 Million
Round Type
Debt Financing
South San FranciscoBiotechnologyHealth CareTherapeuticsBiopharmaInvestors
Description
On March 27, 2026, Denali Therapeutics Inc. closed a funding transaction under the Royalty Agreement, resulting in gross proceeds of $200 million. This funding follows the accelerated approval by the U.S. Food and Drug Administration of tividenofusp alfa
Quick answer
Denali Therapeutics raised $200 Million in a Debt Financing round, dated March 31, 2026. Investors: Royalty Pharma. Denali Therapeutics is based in South San Francisco, California, United States.
- How much did Denali Therapeutics raise?
- Denali Therapeutics raised $200 Million in a Debt Financing round on March 31, 2026.
- Who invested in Denali Therapeutics?
- Royalty Pharma is named as investors in this round.
- What does Denali Therapeutics do?
- Denali Therapeutics is a biotechnology company pioneering a new class of biotherapeutics designed to cross the blood-brain barrier using its proprietary TransportVehicle™ platform.
- Where is Denali Therapeutics based and how big is it?
- Denali Therapeutics is based in South San Francisco, California, United States. Fundz records about 567 employees.
- Who are the decision-makers at Denali Therapeutics?
- Fundz holds 1 contact at Denali Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biopharma around the same time
Companies in the same sectors as Denali Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Citius Oncology raised $37M on May 6, 2026.
- Windward Bio raised $165M (Funding Round) on May 5, 2026.
- Lighthouse Pharmaceuticals raised $15M (Series A) on April 22, 2026.
- Sparian Biosciences raised $15M (Grant) on April 13, 2026.
- Sidewinder Therapeutics raised $137M (Series B) on April 8, 2026.
- Tempest Therapeutics raised $2M on March 20, 2026.
Who to call at Denali Therapeutics, and when
A new round usually means Denali Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Denali Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Denali Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Denali Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Denali Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Denali Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.